Martin J. Brodie
Research Subjects
Research Interests
Martin J. Brodie has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Kwan
Department of Neuroscience, School of Translational Medicine Monash University Melbourne Victoria Australia
9 shared publications Linda J. Stephen
Epilepsy Unit, Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, Scotland
8 shared publications- Graeme John Sills
Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK
4 shared publications - Jacqueline A. French
Comprehensive Epilepsy Center New York University Grossman School of Medicine New York New York USA
2 shared publications Kevin Kelly
Epilepsy Unit, Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow G11 6NT, Scotland, UK
2 shared publications- Rajiv Mohanraj
Department of Neurology, Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, UK; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, UK
2 shared publications
Latest Publications
- 1 June 2011
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 20 (5) , 369-375
Combining antiepileptic drugs—Rational polytherapy?
- 1 June 2011
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 20 (5) , 369-375
Combining antiepileptic drugs—Rational polytherapy?
- 1 February 2011
- Published by Springer Nature in CNS Drugs
- Vol. 25 (2) , 89-107
Pharmacotherapy of Epilepsy
This article discusses seven newly available antiepileptic drugs (AEDs) and agents in phase III development. Lacosamide, licensed as an adjunctive treatment for partial-onset seizures, primarily acts...
- 1 February 2011
- Published by Springer Nature in CNS Drugs
- Vol. 25 (2) , 89-107
Pharmacotherapy of Epilepsy
This article discusses seven newly available antiepileptic drugs (AEDs) and agents in phase III development. Lacosamide, licensed as an adjunctive treatment for partial-onset seizures, primarily acts...
- Open Access
Special problems: Adults and elderly
Summary: A first seizure out of a clear blue sky can be a major life‐changing event. Careful history‐taking and appropriate investigation together with a clear explanation provided to patient and family are an essential requirement. Although for most patients, pharmacotherapy can be withheld and events awaited, there are circumstances where introduction of antiepileptic drug (AED) therapy should be considered. Medical causes of seizures should also be sought and treated. In addition, a first seizure in HIV‐positive patients and in those with underlying neurocysticercosis should usually provoke the introduction of AED therapy. Particular problems can occur in patients with a single episode of provoked status epilepticus, a first tonic–clonic seizure during pregnancy and, particularly, an unprovoked event in older and learning disabled people. Treatment following a first seizure should balance risk factors for recurrence with the informed opinion of the patients and their family.
Open AccessSpecial problems: Adults and elderly
Summary: A first seizure out of a clear blue sky can be a major life‐changing event. Careful history‐taking and appropriate investigation together with a clear explanation provided to patient and family are an essential requirement. Although for most patients, pharmacotherapy can be withheld and events awaited, there are circumstances where introduction of antiepileptic drug (AED) therapy should be considered. Medical causes of seizures should also be sought and treated. In addition, a first seizure in HIV‐positive patients and in those with underlying neurocysticercosis should usually provoke the introduction of AED therapy. Particular problems can occur in patients with a single episode of provoked status epilepticus, a first tonic–clonic seizure during pregnancy and, particularly, an unprovoked event in older and learning disabled people. Treatment following a first seizure should balance risk factors for recurrence with the informed opinion of the patients and their family.
- 5 February 2007
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 115 (3) , 204-208
Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting
Introduction – The prognosis of idiopathic generalized epilepsy syndromes (IGES) in the adult setting may vary from that in children owing to differences in genetic, environmental and lifestyle factors. Methods – All patients diagnosed with epilepsy at the Epilepsy Unit, Western Infirmary, Glasgow, between 1981 and 2001 were reviewed. Results – Of 890 patients, 118 (13%) met the criteria for IGES. Outcomes were known for 103, 66 (64%) of whom achieved remission. The responder rate with sodium valproate was superior (66% vs 45%, P = 0.073) to that with lamotrigine (LTG) particularly in patients with juvenile myoclonic epilepsies (75% vs 39%, P = 0.014). History of febrile seizures was the only factor associated with reduced likelihood of remission (P = 0.032) Conclusions – Idiopathic generalized epilepsy syndromes constituted 13% of cases in a largely adult cohort of newly diagnosed epilepsy, most of whom achieved remission usually with a single antiepileptic drug. History of febrile seizures was associated with a poorer outcome.
- 5 February 2007
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 115 (3) , 204-208
Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting
Introduction – The prognosis of idiopathic generalized epilepsy syndromes (IGES) in the adult setting may vary from that in children owing to differences in genetic, environmental and lifestyle factors. Methods – All patients diagnosed with epilepsy at the Epilepsy Unit, Western Infirmary, Glasgow, between 1981 and 2001 were reviewed. Results – Of 890 patients, 118 (13%) met the criteria for IGES. Outcomes were known for 103, 66 (64%) of whom achieved remission. The responder rate with sodium valproate was superior (66% vs 45%, P = 0.073) to that with lamotrigine (LTG) particularly in patients with juvenile myoclonic epilepsies (75% vs 39%, P = 0.014). History of febrile seizures was the only factor associated with reduced likelihood of remission (P = 0.032) Conclusions – Idiopathic generalized epilepsy syndromes constituted 13% of cases in a largely adult cohort of newly diagnosed epilepsy, most of whom achieved remission usually with a single antiepileptic drug. History of febrile seizures was associated with a poorer outcome.
- Open Access
- 27 March 2006
- Published by Wiley in European Journal of Neurology
- Vol. 13 (3) , 277-282
Diagnosing refractory epilepsy: response to sequential treatment schedules
Diagnosing refractory epilepsy would facilitate referral for specialist pharmacological review and early consideration of epilepsy surgery. An outcomes study was undertaken in an unselected cohort of newly diagnosed patients to determine the number of antiepileptic drug (AED) regimens needed to be failed before the epilepsy could be designated as pharmacoresistant. Between July 1982 and May 2001, 780 adolescents and adults prescribed their first AED at the Western Infirmary in Glasgow, Scotland provided longitudinal data suitable for analysis. Overall, 504 (64.6%) patients became seizure free for at least 12 months. Of these, 462 (59.2%) remained in remission, while 42 (5.4%) relapsed and subsequently developed refractory epilepsy. The relapse rate peaked at 10.4% after 8 years of follow‐up. The other 276 (35.4%) patients were uncontrolled from the outset. Prognosis appeared better in seniors (85% remission, P < 0.001) and adolescents (65% remission, P < 0.01) than in the remainder of the population (55% remission). Overall response rates with the first, second and third treatment schedules were 50.4, 10.7 and 2.7%, respectively, with only 0.8% patients responding optimally to further drug trials. Patients not tolerating at least one AED schedule did better than those failing because of lack of efficacy. These data suggest that suitable patients failing two AED regimens should be referred for epilepsy surgery. Those who do not attain long‐term seizure freedom with the first three treatment schedules are likely to have refractory epilepsy.
- 27 March 2006
- Published by Wiley in European Journal of Neurology
- Vol. 13 (3) , 277-282
Open AccessDiagnosing refractory epilepsy: response to sequential treatment schedules
Diagnosing refractory epilepsy would facilitate referral for specialist pharmacological review and early consideration of epilepsy surgery. An outcomes study was undertaken in an unselected cohort of newly diagnosed patients to determine the number of antiepileptic drug (AED) regimens needed to be failed before the epilepsy could be designated as pharmacoresistant. Between July 1982 and May 2001, 780 adolescents and adults prescribed their first AED at the Western Infirmary in Glasgow, Scotland provided longitudinal data suitable for analysis. Overall, 504 (64.6%) patients became seizure free for at least 12 months. Of these, 462 (59.2%) remained in remission, while 42 (5.4%) relapsed and subsequently developed refractory epilepsy. The relapse rate peaked at 10.4% after 8 years of follow‐up. The other 276 (35.4%) patients were uncontrolled from the outset. Prognosis appeared better in seniors (85% remission, P < 0.001) and adolescents (65% remission, P < 0.01) than in the remainder of the population (55% remission). Overall response rates with the first, second and third treatment schedules were 50.4, 10.7 and 2.7%, respectively, with only 0.8% patients responding optimally to further drug trials. Patients not tolerating at least one AED schedule did better than those failing because of lack of efficacy. These data suggest that suitable patients failing two AED regimens should be referred for epilepsy surgery. Those who do not attain long‐term seizure freedom with the first three treatment schedules are likely to have refractory epilepsy.
- 1 March 2006
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 6 (3) , 397-406
Refractory epilepsy: mechanisms and solutions
(2006). Refractory epilepsy: mechanisms and solutions. Expert Review of Neurotherapeutics: Vol. 6, No. 3, pp. 397-406.
- 1 March 2006
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 6 (3) , 397-406
Refractory epilepsy: mechanisms and solutions
(2006). Refractory epilepsy: mechanisms and solutions. Expert Review of Neurotherapeutics: Vol. 6, No. 3, pp. 397-406.
- 1 January 2006
- Published by Springer Nature in Drugs
- Vol. 66 (14) , 1817-1829
Combination Therapy in Epilepsy
After being regarded as a last resort for over two decades, the role of combination therapy as a treatment strategy for epilepsy is undergoing re-evaluation. This is a result of the growing...
- 1 January 2006
- Published by Springer Nature in Drugs
- Vol. 66 (14) , 1817-1829
Combination Therapy in Epilepsy
After being regarded as a last resort for over two decades, the role of combination therapy as a treatment strategy for epilepsy is undergoing re-evaluation. This is a result of the growing...
- Open Access
Response to Antiepileptic Drug Therapy: Winners and Losers
Summary: Recent evidence suggests that the vast majority of people with epilepsy will respond to their first or second treatment regimen or will be refractory de novo. Two patients with symptomatic epilepsy secondary to underlying cortical dysplasias are presented to illustrate these different scenarios. Clinical observations can provide insights to the processes underlying pharmacoresistance.
Open AccessResponse to Antiepileptic Drug Therapy: Winners and Losers
Summary: Recent evidence suggests that the vast majority of people with epilepsy will respond to their first or second treatment regimen or will be refractory de novo. Two patients with symptomatic epilepsy secondary to underlying cortical dysplasias are presented to illustrate these different scenarios. Clinical observations can provide insights to the processes underlying pharmacoresistance.
Epilepsy in elderly people
We searched Medline, Embase, and the Cochrane Collaboration with the key words “epilepsy”, “seizures”, “elderly”, “aged”, and “anticonvulsants”. We selected articles of interest from 1995 onwards and then hand searched these for earlier publications, focusing on those that specifically included elderly patients and covered clinically relevant topics.
Epilepsy in elderly people
We searched Medline, Embase, and the Cochrane Collaboration with the key words “epilepsy”, “seizures”, “elderly”, “aged”, and “anticonvulsants”. We selected articles of interest from 1995 onwards and then hand searched these for earlier publications, focusing on those that specifically included elderly patients and covered clinically relevant topics.